(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.34%13.98B | -0.98%9.07B | -2.67%4.43B | -5.66%18.17B | -7.72%13.66B | -7.93%9.16B | 0.04%4.55B | 14.71%19.26B | 21.80%14.8B | 18.61%9.95B |
Operating income | 2.34%13.98B | -0.98%9.07B | -2.67%4.43B | -5.66%18.17B | -7.72%13.66B | -7.93%9.16B | 0.04%4.55B | 14.71%19.26B | 21.80%14.8B | 18.61%9.95B |
Operating expenses | -2.44%-8.95B | 1.57%-5.69B | 3.71%-2.74B | 11.39%-11.7B | 12.95%-8.74B | 14.75%-5.78B | 5.15%-2.85B | -15.20%-13.21B | -24.40%-10.04B | -24.23%-6.78B |
Gross profit | 2.16%5.03B | 0.02%3.38B | -0.93%1.69B | 6.85%6.47B | 3.30%4.92B | 6.68%3.38B | 10.08%1.71B | 13.66%6.06B | 16.67%4.76B | 8.13%3.16B |
Selling expenses | 45.37%-54.1M | 48.81%-35.36M | 57.55%-14.61M | 28.80%-76.14M | -33.40%-99.02M | -172.07%-69.07M | -196.21%-34.43M | -93.07%-106.94M | -72.92%-74.23M | 7.66%-25.39M |
Administrative expenses | -9.32%-756.17M | 3.65%-478.75M | 3.90%-229.59M | -8.91%-1.04B | 4.49%-691.7M | -9.90%-496.91M | -37.05%-238.92M | -3.77%-952.09M | -35.02%-724.22M | -9.59%-452.14M |
Research and development expenses | -18.23%-95.31M | -31.56%-66.77M | -9.61%-23.08M | 5.69%-104.94M | 9.38%-80.61M | 9.22%-50.75M | -44.11%-21.06M | -34.34%-111.27M | -167.14%-88.95M | -363.94%-55.91M |
Profit from asset sales | 68.24%17.14M | 345.34%21.85M | 913.43%18.51M | 0.92%15.34M | 1,018.40%10.19M | 259.63%4.91M | 76.84%1.83M | -54.02%15.2M | -93.09%910.91K | -60.71%1.36M |
Revaluation surplus | 286.13%1.9M | 147.40%482.74K | --903.3K | -106.60%-560.51K | -124.04%-1.02M | -211.85%-1.02M | ---- | -57.87%8.49M | -62.44%4.24M | -105.74%-326.55K |
-Changes in the fair value of other assets | 286.13%1.9M | 147.40%482.74K | --903.3K | -106.60%-560.51K | -124.04%-1.02M | -211.85%-1.02M | ---- | -57.87%8.49M | -62.44%4.24M | -105.74%-326.55K |
Impairment and provision | -127.93%-17.54M | -138.50%-22.6M | -152.14%-6.96M | 207.37%26.16M | 254.18%62.8M | 250.12%58.69M | 137.67%13.35M | 48.09%-24.36M | -126.42%-40.73M | 16.73%-39.1M |
-Other impairment is provision | -127.93%-17.54M | -138.50%-22.6M | -152.14%-6.96M | 207.37%26.16M | 254.18%62.8M | 250.12%58.69M | 137.67%13.35M | 48.09%-24.36M | -126.42%-40.73M | 16.73%-39.1M |
Special items of operating profit | 6.53%1.36B | 7.19%901.73M | 2.92%440.87M | 4.94%1.72B | 6.20%1.28B | 6.87%841.22M | 13.63%428.36M | 2.12%1.64B | 11.13%1.2B | -1.05%787.17M |
Operating profit | 1.32%5.35B | 0.80%3.61B | 0.82%1.83B | 7.61%6.86B | 7.12%5.28B | 8.38%3.58B | 9.51%1.82B | 11.20%6.38B | 10.59%4.93B | 4.75%3.31B |
Financing cost | 46.33%-48.02M | 55.27%-23.6M | 76.09%-10.69M | -159.18%-108.78M | -153.94%-89.46M | -142.51%-52.77M | -227.48%-44.71M | 83.71%183.82M | 63.52%165.86M | 194.52%124.14M |
Special items of earning before tax | -116.49%-1.26M | -21.38%1.38M | -145.64%-1.56M | 859.72%36.55M | 106.47%7.64M | 215.51%1.75M | -44.57%3.42M | -748.88%-4.81M | -46.15%3.7M | -587.17%-1.52M |
Earning before tax | 1.97%5.3B | 1.62%3.59B | 2.48%1.82B | 3.57%6.79B | 1.96%5.2B | 3.02%3.53B | 4.42%1.78B | 12.34%6.56B | 11.68%5.1B | 7.19%3.43B |
Tax | -1.88%-970.86M | 0.36%-662.47M | 3.12%-343.47M | 2.56%-1.27B | 9.47%-952.92M | 7.03%-664.89M | -3.28%-354.54M | -11.66%-1.31B | -12.73%-1.05B | -10.51%-715.17M |
After-tax profit from continuing operations | 1.99%4.33B | 2.08%2.93B | 3.87%1.48B | 11.25%5.52B | 4.93%4.25B | 13.42%2.87B | 4.71%1.42B | 13.37%4.96B | 11.41%4.05B | -0.92%2.53B |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.36%290.4M | ---- | --185.4M |
Earning after tax | 1.99%4.33B | 2.08%2.93B | 3.87%1.48B | 5.10%5.52B | 4.93%4.25B | 5.67%2.87B | 4.71%1.42B | 12.51%5.25B | 11.41%4.05B | 6.35%2.71B |
Minority profit | -12.73%402.63M | -6.09%285.48M | -1.74%159.12M | -17.67%594.34M | -23.23%461.36M | -24.21%303.98M | -24.62%161.93M | 5.54%721.9M | 7.42%600.96M | 8.19%401.06M |
Profit attributable to shareholders | 3.78%3.93B | 3.05%2.64B | 4.60%1.32B | 8.72%4.92B | 9.83%3.79B | 10.85%2.56B | 10.23%1.26B | 13.71%4.53B | 12.14%3.45B | 6.04%2.31B |
Basic earnings per share | 5.17%0.61 | 5.13%0.41 | 5.26%0.2 | 8.57%0.76 | 9.43%0.58 | 8.33%0.39 | 5.56%0.19 | 14.75%0.7 | 12.77%0.53 | 5.88%0.36 |
Diluted earnings per share | 5.17%0.61 | 5.13%0.41 | 5.26%0.2 | 8.57%0.76 | 9.43%0.58 | 8.33%0.39 | 5.56%0.19 | 14.75%0.7 | 12.77%0.53 | 5.88%0.36 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data